Olivia Newton-John Cancer Research Institute clinical trial pipeline

2 trials changed in the last 30 days: 0 stopped, 1 with a notable change, 1 with a minor change only.

1. Notable

   TOP-FLOR · Treatment Of Newly-diagnosed Follicular Lymphoma With…TOP-FLOR · Treatment Of Newly-diagnosed Follicular Lymphoma With CELMoD Golcadomide, Rituximab +/- Nivolumab

   Primary completion pushed from Jan 1, 2027 to Jan 1, 2028

   Also in this update: Study completion pushed from Jun 1, 2027 to Jun 1, 2029

   Olivia Newton-John Cancer Research Institute·Phase 2· NCT05788081· Registry history of NCT05788081 on ClinicalTrials.gov (opens the registry)

   Oct 16, 2026

• Stopped: an ongoing trial was terminated, suspended or withdrawn.
• Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
• Minor: routine progress and housekeeping, such as sites added or enrollment closed.